TITLE

Intravitreal injection of triamcinolone acetonide for diabetic macular edema: Principles and practice

AUTHOR(S)
Vedantham, Vasumathy; Kim, Ramasamy
PUB. DATE
June 2006
SOURCE
Indian Journal of Ophthalmology;Jun2006, Vol. 54 Issue 2, p133
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients. Laser photocoagulation, which is the standard treatment of macular edema, is associated with significant complications and an improvement in visual acuity is unsatisfactory. Intravitreal injection of corticosteroids (especially triamcinolone acetonide) is an emerging treatment modality in the management of diabetic macular edema. This article presents an overview of the principles, technique and complications associated with this procedure.
ACCESSION #
21277674

 

Related Articles

  • Pycnogenol® Improves Microcirculation, Retinal Edema, and Visual Acuity in Early Diabetic Retinopathy. Steigerwalt, Robert; Belcaro, Gianni; Cesarone, Maria Rosaria; Di Renzo, Andrea; Grossi, Maria Giovanna; Ricci, Andrea; Dugall, Mark; Cacchio, Marisa; Schönlau, Frank // Journal of Ocular Pharmacology & Therapeutics;Dec2009, Vol. 25 Issue 6, p537 

    Purpose: The growing numbers of diabetes cases in the developed world are followed by increasing numbers of people diagnosed with diabetic complications. Diabetic microangiopathies in the eye lead to the development of retinopathy involving gradual loss of vision. Previous studies with...

  • Visual Fields Refine Understanding of Diabetic Retinopathy Progression. Jackson, Gregory R.; Gardner, Thomas W. // Diabetes;Sep2014, Vol. 63 Issue 9, p2909 

    The article focuses on a study which examined the effect of diabetes on the neural retina. Topics discussed include the finding that deterioration of the neural retina may take place for years without a clinically detectable change in the microvasculature, and evidence showing that diabetic...

  • ROCK as a Therapeutic Target of Diabetic Retinopathy. Arita, Ryoichi; Hata, Yasuaki; Ishibashi, Tatsuro // Journal of Ophthalmology;2010, p1 

    The increasing global prevalence of diabetes is a critical problem for public health. In particular, diabetic retinopathy, a prevalent ocular complication of diabetes mellitus, causes severe vision loss in working population. A better understanding of the pathogenesis and the development of new...

  • The incidence of visual impairment due to diabetic retinopathy in Leeds. Kumar, N.; Goyder, E.; McKibbin, M. // Eye;Apr2006, Vol. 20 Issue 4, p455 

    AimA key aim of the photographic screening model for diabetic retinopathy advocated by the National Screening Committee is a reduction in new blindness due to diabetic retinopathy within 5 years. This study determines the incidence of visual impairment due to diabetic retinopathy in Leeds in...

  • The Link Between Visual Acuity and Health-Related Quality of Life Among Patients with Diabetic Retinopathy. Rousculp, Matthew D.; Boye, Kristina S.; Matza, Louis S.; Malley, Karen; Oglesby, Alan K. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA216 

    The purpose of this study was to characterize the degree of change in health related quality of life (HRQL) associated with change in visual acuity (VA) among patients with diabetic retinopathy (DR). Data were from a multicenter study on vision loss in patients with type 1 or type 2 diabetes and...

  • Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up. Arevalo, J. F.; Wu, L.; Sanchez, J. G.; Maia, M.; Saravia, M. J.; Fernandez, C. F.; Evans, T. // Eye;Jan2009, Vol. 23 Issue 1, p117 

    AimsTo study the effects of intravitreal bevacizumab (Avastin) on retinal neovascularization (RN) in patients with proliferative diabetic retinopathy (PDR).MethodsRetrospective study of patients with RN due to PDR who were treated with at least one intravitreal injection of 1.25 or 2.5 mg of...

  • ROLUL ANGIOFLUOROGRAFIEI ÃŽN STABILIREA DIAGNOSTICULUI ÅžI TRATAMENTULUI RETINOPATIEI DIABETICE. FLORESCU, MIHAELA; STĂNILĂ, ADRIANA // Acta Medica Transilvanica;sep2013, Vol. 18 Issue 3, p80 

    Purpose of the paper: Assessment of retinal fluorescein angiography role in the patients with diabetic retinopathy and implicitly, the role of this method in establishing the diagnosis and the optimal therapy for these patients. Methods: Prospective interventional non-comparative study. We...

  • The Influence on Treatment Efficiency in Diabetic Retinopathy by Laser Photocoagulation Area. Ming Zheng; Zhihua Cui; Xiaoying Hu; Mengmeng Zhang; You Zhou; Chunguang Zhou // Journal of Convergence Information Technology;Aug2012, Vol. 7 Issue 14, p269 

    A computer approach for calculating the laser photocoagulation area from diabetic retinopathy laser therapy images had been proposed and used in this paper. This algorithm used canny edge detection method to find the edges and the connectors in the images. The moderate sized non-linear...

  • Intravitreal Bevacizumab for Diabetic Papillopathy. Örnek, Kemal; Oğurel, Tevfik // Journal of Ocular Pharmacology & Therapeutics;Apr2010, Vol. 26 Issue 2, p217 

    A 43-year-old woman presented with a visual acuity of 1/10 in the right eye and 3/10 in the left eye. Ophthalmologic examination disclosed optic disc swelling on both sides with mild nonproliferative diabetic retinopathy. The pupils were equal and reactive without an afferent pupillary defect....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics